ILC2s, but not CD4+ T cells, presented an increased frequency within the esophagus following IL-33 administration, suggesting a specific role in EoE pathogenesis (Fig. 2M, N, Supplementary Fig. 3E). The gene discussed is IL33; the disease is eosinophilic esophagitis.